Alankit Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 17, 2025, 10:54 am

Market Cap	415 Cr.
Current Price	15.3
High / Low	29.7/12.5
Stock P/E	18.8
Book Value	10.6
Dividend Yield	0.00 %
ROCE	10.7 %
ROE	9.47 %
Face Value	1.00
PEG Ratio	5.35

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Alankit Ltd

Competitors of Alankit Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MKVentures Capital Ltd	559 Cr.	1,455	2,800/1,151	27.2	267	0.07 %	20.6 %	33.6 %	10.0
Modern Shares & Stockbrokers Ltd	12.9 Cr.	44.1	69.4/36.0	37.0	43.9	0.00 %	4.33 %	3.24 %	10.0
Monarch Networth Capital Ltd	2,560 Cr.	326	501/226	16.5	93.0	0.15 %	51.8 %	43.4 %	10.0
Monotype India Ltd	55.6 Cr.	0.79	2.42/0.64	6.95	0.13	0.00 %	438 %	%	1.00
Multipurpose Trading & Agencies Ltd	4.73 Cr.	9.55	13.3/7.93	24.9	10.2	0.00 %	4.44 %	3.91 %	10.0
Industry Average	6,357.22 Cr	1,422.12		85.64	5,272.28	0.35%	18.78%	17.32%	7.38

All Competitor Stocks of Alankit Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	33.93	28.94	34.22	13.19	116.10	148.18	48.62	43.32	52.61	91.16	61.93	64.35	72.77
Expenses	26.79	34.42	27.02	27.86	105.15	139.92	43.26	38.70	49.05	80.79	53.72	58.94	66.14
Operating Profit	7.14	-5.48	7.20	-14.67	10.95	8.26	5.36	4.62	3.56	10.37	8.21	5.41	6.63
OPM %	21.04%	-18.94%	21.04%	-111.22%	9.43%	5.57%	11.02%	10.66%	6.77%	11.38%	13.26%	8.41%	9.11%
Other Income	1.28	3.17	1.58	-36.85	-6.81	2.08	2.45	2.47	5.76	1.16	3.11	3.85	1.95
Interest	0.51	0.35	0.48	0.49	0.52	0.13	0.25	0.60	0.56	-0.29	0.86	0.95	0.97
Depreciation	2.17	2.40	2.13	1.90	1.97	2.47	1.94	1.91	1.88	1.94	1.90	2.16	2.77
Profit before tax	5.74	-5.06	6.17	-53.91	1.65	7.74	5.62	4.58	6.88	9.88	8.56	6.15	4.84
Tax %	61.32%	-14.03%	24.64%	-7.81%	-161.21%	27.52%	13.70%	44.54%	-18.02%	34.62%	12.03%	40.49%	-7.44%
Net Profit	2.21	-4.34	4.65	-49.69	4.31	5.60	4.85	2.54	8.12	6.47	7.53	3.67	5.20
EPS in Rs	0.15	-0.31	0.31	-3.24	0.24	0.21	0.21	0.09	0.36	0.24	0.27	0.12	0.19

Last Updated: February 28, 2025, 8:43 pm

Below is a detailed analysis of the quarterly data for Alankit Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 72.77 Cr.. The value appears strong and on an upward trend. It has increased from 64.35 Cr. (Sep 2024) to 72.77 Cr., marking an increase of 8.42 Cr..
For Expenses, as of Dec 2024, the value is 66.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 58.94 Cr. (Sep 2024) to 66.14 Cr., marking an increase of 7.20 Cr..
For Operating Profit, as of Dec 2024, the value is 6.63 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Sep 2024) to 6.63 Cr., marking an increase of 1.22 Cr..
For OPM %, as of Dec 2024, the value is 9.11%. The value appears strong and on an upward trend. It has increased from 8.41% (Sep 2024) to 9.11%, marking an increase of 0.70%.
For Other Income, as of Dec 2024, the value is 1.95 Cr.. The value appears to be declining and may need further review. It has decreased from 3.85 Cr. (Sep 2024) to 1.95 Cr., marking a decrease of 1.90 Cr..
For Interest, as of Dec 2024, the value is 0.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.95 Cr. (Sep 2024) to 0.97 Cr., marking an increase of 0.02 Cr..
For Depreciation, as of Dec 2024, the value is 2.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.16 Cr. (Sep 2024) to 2.77 Cr., marking an increase of 0.61 Cr..
For Profit before tax, as of Dec 2024, the value is 4.84 Cr.. The value appears to be declining and may need further review. It has decreased from 6.15 Cr. (Sep 2024) to 4.84 Cr., marking a decrease of 1.31 Cr..
For Tax %, as of Dec 2024, the value is -7.44%. The value appears to be improving (decreasing) as expected. It has decreased from 40.49% (Sep 2024) to -7.44%, marking a decrease of 47.93%.
For Net Profit, as of Dec 2024, the value is 5.20 Cr.. The value appears strong and on an upward trend. It has increased from 3.67 Cr. (Sep 2024) to 5.20 Cr., marking an increase of 1.53 Cr..
For EPS in Rs, as of Dec 2024, the value is 0.19. The value appears strong and on an upward trend. It has increased from 0.12 (Sep 2024) to 0.19, marking an increase of 0.07.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:20 pm

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	3	31	85	105	130	156	115	128	312	236	290
Expenses	3	22	64	76	110	132	96	117	299	210	260
Operating Profit	-1	9	21	29	21	24	19	11	13	26	31
OPM %	-27%	28%	25%	28%	16%	15%	17%	9%	4%	11%	11%
Other Income	2	0	2	4	8	7	3	9	-40	12	10
Interest	0	0	1	3	2	3	4	3	2	3	2
Depreciation	0	3	1	4	4	5	4	9	8	8	9
Profit before tax	1	5	20	26	22	23	15	8	-38	27	29
Tax %	64%	29%	35%	16%	35%	38%	24%	66%	-8%	19%
Net Profit	0	4	13	22	14	14	11	3	-35	22	23
EPS in Rs	0.03	0.26	0.93	1.52	0.98	0.98	0.69	0.17	-1.50	0.80	0.82
Dividend Payout %	193%	39%	22%	13%	20%	20%	29%	121%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	225.00%	69.23%	-36.36%	0.00%	-21.43%	-72.73%	-1266.67%	162.86%
Change in YoY Net Profit Growth (%)	0.00%	-155.77%	-105.59%	36.36%	-21.43%	-51.30%	-1193.94%	1429.52%

Alankit Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2016-2017 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	13%
3 Years:	27%
TTM:	-1%

Compounded Profit Growth
10 Years:	%
5 Years:	8%
3 Years:	28%
TTM:	13%

Stock Price CAGR
10 Years:	3%
5 Years:	0%
3 Years:	1%
1 Year:	-10%

Return on Equity
10 Years:	%
5 Years:	10%
3 Years:	9%
Last Year:	9%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:44 am

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	7	7	14	14	14	14	14	14	22	27	27
Reserves	24	28	33	49	59	73	80	119	139	249	260
Borrowings	0	0	5	5	14	13	14	21	13	44	33
Other Liabilities	1	16	26	58	53	71	57	107	128	211	154
Total Liabilities	33	51	78	126	140	172	165	261	302	531	474
Fixed Assets	1	28	28	36	55	50	68	87	56	50	73
CWIP	0	0	0	18	16	18	1	0	0	9	0
Investments	1	0	2	1	1	0	1	12	11	21	36
Other Assets	30	23	49	70	68	104	97	161	236	451	365
Total Assets	33	51	78	126	140	172	165	261	302	531	474

Below is a detailed analysis of the balance sheet data for Alankit Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
For Reserves, as of Sep 2024, the value is ₹260.00 Cr.. The value appears strong and on an upward trend. It has increased from 249.00 Cr. (Mar 2024) to ₹260.00 Cr., marking an increase of 11.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹33.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 44.00 Cr. (Mar 2024) to ₹33.00 Cr., marking a decrease of 11.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹154.00 Cr.. The value appears to be improving (decreasing). It has decreased from 211.00 Cr. (Mar 2024) to ₹154.00 Cr., marking a decrease of 57.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹474.00 Cr.. The value appears to be improving (decreasing). It has decreased from 531.00 Cr. (Mar 2024) to ₹474.00 Cr., marking a decrease of 57.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹73.00 Cr.. The value appears strong and on an upward trend. It has increased from 50.00 Cr. (Mar 2024) to ₹73.00 Cr., marking an increase of 23.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 9.00 Cr..
For Investments, as of Sep 2024, the value is ₹36.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to ₹36.00 Cr., marking an increase of 15.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹365.00 Cr.. The value appears to be declining and may need further review. It has decreased from 451.00 Cr. (Mar 2024) to ₹365.00 Cr., marking a decrease of 86.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹474.00 Cr.. The value appears to be declining and may need further review. It has decreased from 531.00 Cr. (Mar 2024) to ₹474.00 Cr., marking a decrease of 57.00 Cr..

Notably, the Reserves (260.00 Cr.) exceed the Borrowings (33.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	2	18	2	28	19	-9	-2	2	-49	10
Cash from Investing Activity +	-4	-29	-1	-27	-22	4	-3	-27	-19	-80
Cash from Financing Activity +	11	12	2	1	4	-2	-3	41	63	122
Net Cash Flow	10	1	3	2	0	-7	-8	15	-6	51

Free Cash Flow

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-1.00	9.00	16.00	24.00	7.00	11.00	5.00	-10.00	0.00	-18.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	106	69	54	49	78	89	110	131	80	111
Inventory Days	1,297	247	76	142	288	57	119	62	9	31
Days Payable	288	59	92	1,274	561	274	316	221	47	153
Cash Conversion Cycle	1,114	257	38	-1,083	-196	-129	-88	-28	41	-10
Working Capital Days	2,506	91	48	21	41	97	163	52	112	5
ROCE %		16%	50%	47%	30%	24%	17%	8%	8%	11%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	63.77%	54.86%	54.86%	54.86%	54.86%	54.86%	52.03%	52.03%	52.03%	52.03%	54.14%	54.14%
FIIs	0.60%	0.82%	0.36%	0.04%	0.02%	0.00%	0.00%	0.00%	0.07%	0.86%	0.37%	0.60%
DIIs	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	35.62%	44.30%	44.76%	45.08%	45.11%	45.12%	47.95%	47.96%	47.89%	47.11%	45.49%	45.24%
No. of Shareholders	42,076	44,503	60,128	59,446	57,523	55,514	55,431	54,381	64,493	86,739	94,624	88,032

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	0.96	-2.07	0.16	0.77	0.98
Diluted EPS (Rs.)	0.96	-2.07	0.16	0.77	0.98
Cash EPS (Rs.)	1.09	-1.19	0.80	1.08	1.34
Book Value[Excl.RevalReserv]/Share (Rs.)	10.95	8.07	10.12	6.88	6.33
Book Value[Incl.RevalReserv]/Share (Rs.)	10.95	8.07	10.12	6.88	6.33
Revenue From Operations / Share (Rs.)	8.69	13.88	8.96	8.04	10.92
PBDIT / Share (Rs.)	1.32	0.97	1.31	1.44	2.05
PBIT / Share (Rs.)	1.04	0.59	0.69	1.13	1.68
PBT / Share (Rs.)	0.99	-1.71	0.58	1.02	1.57
Net Profit / Share (Rs.)	0.81	-1.56	0.20	0.77	0.97
NP After MI And SOA / Share (Rs.)	0.79	-1.50	0.16	0.77	0.97
PBDIT Margin (%)	15.17	7.00	14.56	17.91	18.73
PBIT Margin (%)	11.91	4.28	7.76	14.09	15.37
PBT Margin (%)	11.43	-12.30	6.55	12.67	14.42
Net Profit Margin (%)	9.32	-11.26	2.24	9.62	8.94
NP After MI And SOA Margin (%)	9.14	-10.82	1.83	9.62	8.94
Return on Networth / Equity (%)	7.80	-20.95	1.76	11.74	15.92
Return on Capital Employeed (%)	9.17	6.67	5.84	12.60	19.21
Return On Assets (%)	4.05	-11.16	0.90	6.69	8.13
Long Term Debt / Equity (X)	0.02	0.04	0.05	0.09	0.08
Total Debt / Equity (X)	0.15	0.08	0.15	0.14	0.14
Asset Turnover Ratio (%)	0.56	1.11	0.60	0.68	1.00
Current Ratio (X)	1.16	2.09	1.37	2.46	2.13
Quick Ratio (X)	1.13	2.04	1.26	2.34	2.03
Dividend Payout Ratio (NP) (%)	0.00	0.00	121.32	25.81	0.00
Dividend Payout Ratio (CP) (%)	0.00	0.00	25.84	18.48	0.00
Earning Retention Ratio (%)	0.00	0.00	-21.32	74.19	0.00
Cash Earning Retention Ratio (%)	0.00	0.00	74.16	81.52	0.00
Interest Coverage Ratio (X)	31.83	13.43	11.95	12.61	19.72
Interest Coverage Ratio (Post Tax) (X)	20.57	10.20	2.84	7.78	10.41
Enterprise Value (Cr.)	477.53	180.29	198.90	237.14	151.52
EV / Net Operating Revenue (X)	2.03	0.57	1.55	2.06	0.97
EV / EBITDA (X)	13.35	8.26	10.66	11.51	5.18
MarketCap / Net Operating Revenue (X)	2.04	0.52	1.47	1.97	0.97
Retention Ratios (%)	0.00	0.00	-21.32	74.18	0.00
Price / BV (X)	1.74	1.02	1.42	2.40	1.73
Price / Net Operating Revenue (X)	2.04	0.52	1.47	1.97	0.97
EarningsYield	0.04	-0.20	0.01	0.04	0.09

After reviewing the key financial ratios for Alankit Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.96. This value is below the healthy minimum of 5. It has increased from -2.07 (Mar 23) to 0.96, marking an increase of 3.03.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.96. This value is below the healthy minimum of 5. It has increased from -2.07 (Mar 23) to 0.96, marking an increase of 3.03.
For Cash EPS (Rs.), as of Mar 24, the value is 1.09. This value is below the healthy minimum of 3. It has increased from -1.19 (Mar 23) to 1.09, marking an increase of 2.28.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 10.95. It has increased from 8.07 (Mar 23) to 10.95, marking an increase of 2.88.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 10.95. It has increased from 8.07 (Mar 23) to 10.95, marking an increase of 2.88.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 8.69. It has decreased from 13.88 (Mar 23) to 8.69, marking a decrease of 5.19.
For PBDIT / Share (Rs.), as of Mar 24, the value is 1.32. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 23) to 1.32, marking an increase of 0.35.
For PBIT / Share (Rs.), as of Mar 24, the value is 1.04. This value is within the healthy range. It has increased from 0.59 (Mar 23) to 1.04, marking an increase of 0.45.
For PBT / Share (Rs.), as of Mar 24, the value is 0.99. This value is within the healthy range. It has increased from -1.71 (Mar 23) to 0.99, marking an increase of 2.70.
For Net Profit / Share (Rs.), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 2. It has increased from -1.56 (Mar 23) to 0.81, marking an increase of 2.37.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.79. This value is below the healthy minimum of 2. It has increased from -1.50 (Mar 23) to 0.79, marking an increase of 2.29.
For PBDIT Margin (%), as of Mar 24, the value is 15.17. This value is within the healthy range. It has increased from 7.00 (Mar 23) to 15.17, marking an increase of 8.17.
For PBIT Margin (%), as of Mar 24, the value is 11.91. This value is within the healthy range. It has increased from 4.28 (Mar 23) to 11.91, marking an increase of 7.63.
For PBT Margin (%), as of Mar 24, the value is 11.43. This value is within the healthy range. It has increased from -12.30 (Mar 23) to 11.43, marking an increase of 23.73.
For Net Profit Margin (%), as of Mar 24, the value is 9.32. This value is within the healthy range. It has increased from -11.26 (Mar 23) to 9.32, marking an increase of 20.58.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.14. This value is within the healthy range. It has increased from -10.82 (Mar 23) to 9.14, marking an increase of 19.96.
For Return on Networth / Equity (%), as of Mar 24, the value is 7.80. This value is below the healthy minimum of 15. It has increased from -20.95 (Mar 23) to 7.80, marking an increase of 28.75.
For Return on Capital Employeed (%), as of Mar 24, the value is 9.17. This value is below the healthy minimum of 10. It has increased from 6.67 (Mar 23) to 9.17, marking an increase of 2.50.
For Return On Assets (%), as of Mar 24, the value is 4.05. This value is below the healthy minimum of 5. It has increased from -11.16 (Mar 23) to 4.05, marking an increase of 15.21.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 23) to 0.02, marking a decrease of 0.02.
For Total Debt / Equity (X), as of Mar 24, the value is 0.15. This value is within the healthy range. It has increased from 0.08 (Mar 23) to 0.15, marking an increase of 0.07.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.56. It has decreased from 1.11 (Mar 23) to 0.56, marking a decrease of 0.55.
For Current Ratio (X), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 1.5. It has decreased from 2.09 (Mar 23) to 1.16, marking a decrease of 0.93.
For Quick Ratio (X), as of Mar 24, the value is 1.13. This value is within the healthy range. It has decreased from 2.04 (Mar 23) to 1.13, marking a decrease of 0.91.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Interest Coverage Ratio (X), as of Mar 24, the value is 31.83. This value is within the healthy range. It has increased from 13.43 (Mar 23) to 31.83, marking an increase of 18.40.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 20.57. This value is within the healthy range. It has increased from 10.20 (Mar 23) to 20.57, marking an increase of 10.37.
For Enterprise Value (Cr.), as of Mar 24, the value is 477.53. It has increased from 180.29 (Mar 23) to 477.53, marking an increase of 297.24.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.03. This value is within the healthy range. It has increased from 0.57 (Mar 23) to 2.03, marking an increase of 1.46.
For EV / EBITDA (X), as of Mar 24, the value is 13.35. This value is within the healthy range. It has increased from 8.26 (Mar 23) to 13.35, marking an increase of 5.09.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.04. This value is within the healthy range. It has increased from 0.52 (Mar 23) to 2.04, marking an increase of 1.52.
For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Price / BV (X), as of Mar 24, the value is 1.74. This value is within the healthy range. It has increased from 1.02 (Mar 23) to 1.74, marking an increase of 0.72.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.04. This value is within the healthy range. It has increased from 0.52 (Mar 23) to 2.04, marking an increase of 1.52.
For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 23) to 0.04, marking an increase of 0.24.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Alankit Ltd as of April 17, 2025 is: 15.40

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 17, 2025, Alankit Ltd is Undervalued by 0.65% compared to the current share price 15.30

Intrinsic Value of Alankit Ltd as of April 17, 2025 is: 15.94

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 17, 2025, Alankit Ltd is Undervalued by 4.18% compared to the current share price 15.30

Last 5 Year EPS CAGR: 3.51%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock is trading at a low valuation with an average P/B ratio of 1.03 and average Dividend Yield of 10.68%. The stock has a high average ROCE of 21.10%, which is a positive sign. The stock has a low average Cash Conversion Cycle of -11.50, which is a positive sign. The company has higher reserves (101.18 cr) compared to borrowings (14.73 cr), indicating strong financial stability. The company has shown consistent growth in sales (144.64 cr) and profit (12.55 cr) over the years.	The stock has a high average Working Capital Days of 63.20, which may not be favorable.

Strength

Weakness

The stock is trading at a low valuation with an average P/B ratio of 1.03 and average Dividend Yield of 10.68%.
The stock has a high average ROCE of 21.10%, which is a positive sign.
The stock has a low average Cash Conversion Cycle of -11.50, which is a positive sign.
The company has higher reserves (101.18 cr) compared to borrowings (14.73 cr), indicating strong financial stability.
The company has shown consistent growth in sales (144.64 cr) and profit (12.55 cr) over the years.

The stock has a high average Working Capital Days of 63.20, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alankit Ltd:
1. Net Profit Margin: 9.32%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 9.17% (Industry Average ROCE: 18.53%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 7.8% (Industry Average ROE: 15.81%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 20.57
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.13
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 18.8 (Industry average Stock P/E: 64.95)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.15
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Alankit Ltd. is a Public Limited Listed company incorporated on 05/07/1989 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74900DL1989PLC036860 and registration number is 036860. Currently Company is involved in the business activities of Other data processing, hosting and related activities. Company's Total Operating Revenue is Rs. 126.64 Cr. and Equity Capital is Rs. 27.12 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Finance & Investments	205-208, Anarkali Complex, New Delhi Delhi 110055	investor@alankit.com http://www.alankit.in

Management
Name	Position Held
Mr. Ashok Kumar Sinha	Chairman & Ind.Director
Mr. Ankit Agarwal	Managing Director
Mrs. Preeti Chadha	Non Executive Director
Mrs. Meera Lal	Non Executive Director
Mr. Raja Gopal Reddy Guduru	Non Executive Director
Ms. Meenu Agrawal	Independent Director

FAQ

What is the intrinsic value of Alankit Ltd?

Alankit Ltd's intrinsic value (as of 17 April 2025) is ₹15.40 — 0.65% higher the current market price of 15.30, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 415 Cr. market cap, FY2025-2026 high/low of ₹29.7/12.5, reserves of 260 Cr, and liabilities of 474 Cr.

What is the Market Cap of Alankit Ltd?

The Market Cap of Alankit Ltd is 415 Cr..

What is the current Stock Price of Alankit Ltd as on 17 April 2025?

The current stock price of Alankit Ltd as on 17 April 2025 is 15.3.

What is the High / Low of Alankit Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Alankit Ltd stocks is ₹29.7/12.5.

What is the Stock P/E of Alankit Ltd?

The Stock P/E of Alankit Ltd is 18.8.

What is the Book Value of Alankit Ltd?

The Book Value of Alankit Ltd is 10.6.

What is the Dividend Yield of Alankit Ltd?

The Dividend Yield of Alankit Ltd is 0.00 %.

What is the ROCE of Alankit Ltd?

The ROCE of Alankit Ltd is 10.7 %.

What is the ROE of Alankit Ltd?

The ROE of Alankit Ltd is 9.47 %.

What is the Face Value of Alankit Ltd?

The Face Value of Alankit Ltd is 1.00.